KR102837618B1 - 혈액에 산소를 공급하기 위한 투석 시스템 및 투석액에 산소를 공급하기 위한 방법 - Google Patents

혈액에 산소를 공급하기 위한 투석 시스템 및 투석액에 산소를 공급하기 위한 방법

Info

Publication number
KR102837618B1
KR102837618B1 KR1020187017421A KR20187017421A KR102837618B1 KR 102837618 B1 KR102837618 B1 KR 102837618B1 KR 1020187017421 A KR1020187017421 A KR 1020187017421A KR 20187017421 A KR20187017421 A KR 20187017421A KR 102837618 B1 KR102837618 B1 KR 102837618B1
Authority
KR
South Korea
Prior art keywords
blood
dialysate
oxygen
delete delete
dialysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020187017421A
Other languages
English (en)
Korean (ko)
Other versions
KR20180084125A (ko
Inventor
베른하르트 크레이만
크리스토프 휘스테게
Original Assignee
아드비토스 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아드비토스 게엠베하 filed Critical 아드비토스 게엠베하
Publication of KR20180084125A publication Critical patent/KR20180084125A/ko
Application granted granted Critical
Publication of KR102837618B1 publication Critical patent/KR102837618B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1698—Blood oxygenators with or without heat-exchangers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1676—Dialysates therefor containing proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1694—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
    • A61M1/1696—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3666—Cardiac or cardiopulmonary bypass, e.g. heart-lung machines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369—Temperature treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0208—Oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0225—Carbon oxides, e.g. Carbon dioxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/03—Gases in liquid phase, e.g. cryogenic liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/202—Blood composition characteristics partial carbon oxide pressure, e.g. partial dioxide pressure (P-CO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/208—Blood composition characteristics pH-value

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020187017421A 2015-11-20 2016-11-18 혈액에 산소를 공급하기 위한 투석 시스템 및 투석액에 산소를 공급하기 위한 방법 Active KR102837618B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2015/002331 2015-11-20
PCT/EP2015/002331 WO2017084683A1 (en) 2015-11-20 2015-11-20 Method for extracorporeal lung support
PCT/EP2016/078198 WO2017085292A1 (en) 2015-11-20 2016-11-18 Method for extracorporeal lung support

Publications (2)

Publication Number Publication Date
KR20180084125A KR20180084125A (ko) 2018-07-24
KR102837618B1 true KR102837618B1 (ko) 2025-07-22

Family

ID=54608483

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187017421A Active KR102837618B1 (ko) 2015-11-20 2016-11-18 혈액에 산소를 공급하기 위한 투석 시스템 및 투석액에 산소를 공급하기 위한 방법

Country Status (14)

Country Link
US (1) US11583620B2 (https=)
EP (2) EP4011416A1 (https=)
JP (1) JP6983793B2 (https=)
KR (1) KR102837618B1 (https=)
CN (1) CN108367109B (https=)
AU (1) AU2016356068B2 (https=)
BR (1) BR112018007200A2 (https=)
CA (1) CA3000927A1 (https=)
DK (1) DK3377139T3 (https=)
ES (1) ES2905621T3 (https=)
IL (1) IL258481B (https=)
MX (1) MX2018006089A (https=)
PL (1) PL3377139T3 (https=)
WO (2) WO2017084683A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017084683A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal lung support
WO2017084682A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal carbon dioxide removal
DK3429657T3 (da) 2016-03-14 2022-06-13 Advitos Gmbh Systemer eller apparater til at udføre dialyse.
EP3634530B1 (en) * 2017-05-22 2025-07-02 ADVITOS GmbH Methods and systems for removing carbon dioxide
WO2019055933A2 (en) 2017-09-17 2019-03-21 Keller Steven Paul SYSTEMS, DEVICES AND METHODS FOR EXTRACORPOREAL CARBON DIOXIDE REMOVAL
CN108211032B (zh) 2018-02-01 2023-11-17 南方医科大学珠江医院 组合型生物人工肝支持系统
JP7301509B2 (ja) * 2018-09-06 2023-07-03 聡 安斎 治療装置
WO2020154638A1 (en) 2019-01-25 2020-07-30 Transonic Systems, Inc. Method and apparatus for assessing cardiac output in veno-venous extracorporeal blood oxygenation
US11633525B2 (en) 2019-01-29 2023-04-25 Transonic Systems Inc. Method and apparatus for assessing cardiac output in veno-arterial extracorporeal blood oxygenation
IL285848B2 (en) * 2019-02-26 2024-10-01 Digital Blood Corp System for non-invasive examination of blood environment parameters
US20220031921A1 (en) * 2019-04-29 2022-02-03 Verthermia Acquisition, Inc. Method and System for Controlled Hyperthermia
US11065379B2 (en) * 2019-04-30 2021-07-20 Veryhermia Acquistion, Inc. Method and system for controlled hyperthermia
JP7347857B2 (ja) * 2019-05-02 2023-09-20 トランソニック システムズ インク 静脈－静脈体外血液酸素化を受けている患者の心拍出量の計算
DE102019007144A1 (de) * 2019-10-15 2021-04-15 ProMedTec Germany GmbH Verfahren und Anordnung zur Verbesserung des Austausches von Gasen über semipermeable Membranen im wässrigen Milieu
DE102020104117A1 (de) * 2020-02-18 2021-08-19 Universität des Saarlandes Vorrichtung zum Entfernen eines Gases aus einer wässrigen Flüssigkeit
CN115916283B (zh) * 2020-04-07 2026-01-16 Gis风险投资公司 将溶解氧输注到静脉内流体中以为受损患者或创伤患者提供静脉血液的短期紧急充氧
EP4251227A4 (en) * 2020-12-01 2024-07-10 Boundless Science, LLC Method and apparatus for enhanced transport
US11219551B1 (en) * 2021-04-25 2022-01-11 Verthermia Acquisition, Inc. Method and system for controlled hyperthermia
WO2024024459A1 (ja) * 2022-07-28 2024-02-01 国立大学法人 東京大学 血漿交換システム、及び血漿交換システムの制御方法
JP2024064862A (ja) * 2022-10-28 2024-05-14 株式会社ジェイ・エム・エス 血液浄化システム及び中間システム

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050082225A1 (en) 2002-05-14 2005-04-21 Bernhard Kreymann Means for removing protein-bound substances
JP2011505209A (ja) * 2007-12-03 2011-02-24 ヘパ ウォッシュ ゲゼルシャフト ミット ベシュレンクテル ハフツング 透析液再生ユニット
US20120190103A1 (en) 2009-02-12 2012-07-26 Novalung Gmbh Device for the treatment of biological fluid
JP2012228285A (ja) * 2011-04-23 2012-11-22 Sunceramics Corp 酸素濃度を高めた透析液

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375414A (en) 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US3771658A (en) * 1971-10-20 1973-11-13 R Brumfield Blood transport membrane pump
US3846236A (en) * 1971-10-22 1974-11-05 Wisconsin Alumni Res Found Method and apparatus for dialysis
SE7403799L (https=) 1974-03-21 1975-09-22 Gambro Ab
DE3230540A1 (de) 1982-08-17 1984-02-23 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Verfahren und vorrichtung zur entfernung von protein- oder lipidgebundenen toxinen aus blut oder blutfraktionen
US4663049A (en) 1984-07-05 1987-05-05 University Of Utah Process for therapeutic dissociation of immune complexes and removal of antigens
IT8504923V0 (it) 1985-06-07 1985-06-07 Miren Srl Dispositivo per il controllo del bilancio idrico di un paziente durante il trattamento di emodialisi
FR2651438A1 (fr) 1989-09-07 1991-03-08 Fondation Nale Transfusion San Procede d'inactivation par ultrasons d'agents infectieux ou parasitaires dans des milieux biologiques et applications du procede.
US6344489B1 (en) 1991-02-14 2002-02-05 Wayne State University Stabilized gas-enriched and gas-supersaturated liquids
DE4309410A1 (de) 1993-03-19 1995-02-16 Stange Jan Material, Verfahren und Einrichtung zur selektiven Trennung frei gelöster und stoffgebundener Stoffe aus flüssigen Stoffgemischen sowie Verfahren zur Herstellung des Materials
US5753227A (en) 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
US5561115A (en) 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
US6607698B1 (en) * 1997-08-15 2003-08-19 Therox, Inc. Method for generalized extracorporeal support
US6264680B1 (en) 1998-01-23 2001-07-24 Viacirq, Inc. Apparatuses and processes for whole-body hyperthermia
JP4061775B2 (ja) 1998-05-21 2008-03-19 ニプロ株式会社 アルブミン含有腹膜透析液
JP2000072658A (ja) 1998-06-17 2000-03-07 Nissho Corp 腹膜透析液および腹膜透析法
DE69929555T8 (de) 1998-06-17 2007-05-31 Nipro Corp. Verwendung einer Flüssigkeit zur Herstellung einer Dialyselösung für die kontinuierliche rezirkulierende Peritonealdialyse
DE19831061A1 (de) 1998-07-10 2000-01-13 Rotkreuzstiftung Zentrallab Herstellung von Proteinpräparationen mit verringertem Aggregatgehalt
US7670491B2 (en) 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
AU2001227865A1 (en) 2000-01-11 2001-07-24 Nephros, Inc. Ionic enhanced dialysis/diafiltration system
CA2396853A1 (en) 2000-01-11 2001-07-19 Nephros, Inc. Thermally enhanced dialysis/diafiltration system
CA2365787C (en) 2000-12-20 2006-02-14 Dialysis Solutions Inc. Sterile low bicarbonate dialysis concentrate solutions
US7241272B2 (en) 2001-11-13 2007-07-10 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
EP1362605A1 (de) 2002-05-14 2003-11-19 Bernhard Dr. Kreymann Dialysevorrichtung zur Entfernung proteingebundener Substanzen
US7112273B2 (en) 2002-09-27 2006-09-26 Nxstage Medical, Inc. Volumetric fluid balance control for extracorporeal blood treatment
US7686778B2 (en) 2003-01-15 2010-03-30 Nxstage Medical, Inc. Waste balancing for extracorporeal blood treatment systems
ITMI20030212A1 (it) 2003-02-07 2004-08-08 Gambro Lundia Ab Metodo per il trattamento extracorporeo di sangue
US7169303B2 (en) 2003-05-28 2007-01-30 Hemocleanse Technologies, Llc Sorbent reactor for extracorporeal blood treatment systems, peritoneal dialysis systems, and other body fluid treatment systems
PL1691863T3 (pl) 2003-10-13 2008-07-31 Fresenius Medical Care Deutschland Gmbh Urządzenie do realizacji terapii z dializą otrzewnową
JP4903583B2 (ja) 2003-12-24 2012-03-28 ケミカ テクノロジーズ， インコーポレイテッド 携帯式個人透析用透析液再生システム
FR2873925B1 (fr) * 2004-08-05 2006-10-13 Erytech Pharma Soc Par Actions Procede et dispositif de lyse-rescellement pour l'incorporation de principe actif notamment asparaginase ou inositol hexaphosphate, dans des erythrocytes
EP1649883A1 (en) 2004-10-19 2006-04-26 MRI S.r.l. Società Unipersonale A CO2 removal device for removing carbon dioxide from blood or from a fluid taken from patient's cardio-circulatory system
JP4908044B2 (ja) 2006-04-14 2012-04-04 株式会社ジェイ・エム・エス 重量検出装置及びバランス制御装置
US20090018484A1 (en) * 2007-07-11 2009-01-15 Levitov Alexander B System device and method for oxygenation
AU2010234206B2 (en) 2009-04-06 2016-10-27 Crearene Ag Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds
DK177144B1 (en) * 2009-06-19 2012-02-06 Aquaporin As A liquid membrane suitable for water extraction
CN102107031A (zh) * 2009-12-28 2011-06-29 天津市海河医院 血液血浆中毒素滤过吸附器及其制备方法和应用
DE102010023635A1 (de) 2010-06-14 2011-12-15 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zum Fördern von Flüssigkeiten in die Behandlungseinheit einer medizinischen Behandlungsvorrichtung, insbesondere in den Dialysator einer Dialysevorrichtung
PL2644215T3 (pl) 2012-03-28 2015-04-30 Gambro Lundia Ab Aparat do pozaustrojowej obróbki krwi
EP2653178A1 (de) 2012-04-16 2013-10-23 Zentrum für biomedizinische Technologie der Donau- Universität Krems Sicherheitseinrichtung für eine extrakorporale Blutbehandlung
GB201207543D0 (en) * 2012-05-01 2012-06-13 Haemair Ltd Treatment of transfusion blood
CN102940886B (zh) 2012-12-13 2015-02-18 鼎正动物药业（天津）有限公司 一种生物屏障渗透剂及其制备方法
US10322221B2 (en) 2013-01-18 2019-06-18 University of Pittsburgh—of the Commonwealth System of Higher Education Removal of carbon dioxide via dialysis
US20160022897A1 (en) 2013-03-13 2016-01-28 Nxstage Medical, Inc. Single pass dialysis combined with multiple pass albumin dialysis
DE102013019356A1 (de) 2013-11-19 2015-06-03 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zum Bilanzieren von Flüssigkeiten für eine extrakorporale Blutbehandlungsvorrichtung
WO2017084682A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal carbon dioxide removal
WO2017084683A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal lung support
EP3634530B1 (en) 2017-05-22 2025-07-02 ADVITOS GmbH Methods and systems for removing carbon dioxide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050082225A1 (en) 2002-05-14 2005-04-21 Bernhard Kreymann Means for removing protein-bound substances
JP2011505209A (ja) * 2007-12-03 2011-02-24 ヘパ ウォッシュ ゲゼルシャフト ミット ベシュレンクテル ハフツング 透析液再生ユニット
US20120190103A1 (en) 2009-02-12 2012-07-26 Novalung Gmbh Device for the treatment of biological fluid
JP2012228285A (ja) * 2011-04-23 2012-11-22 Sunceramics Corp 酸素濃度を高めた透析液

Also Published As

Publication number Publication date
WO2017084683A1 (en) 2017-05-26
ES2905621T3 (es) 2022-04-11
AU2016356068B2 (en) 2021-07-01
AU2016356068A1 (en) 2018-04-12
US20190030232A1 (en) 2019-01-31
CA3000927A1 (en) 2017-05-26
MX2018006089A (es) 2018-11-09
EP4011416A1 (en) 2022-06-15
PL3377139T3 (pl) 2022-05-16
WO2017085292A1 (en) 2017-05-26
JP6983793B2 (ja) 2021-12-17
IL258481B (en) 2021-08-31
US11583620B2 (en) 2023-02-21
EP3377139A1 (en) 2018-09-26
CN108367109A (zh) 2018-08-03
JP2018538118A (ja) 2018-12-27
BR112018007200A2 (pt) 2018-10-16
IL258481A (en) 2018-06-28
DK3377139T3 (da) 2022-01-24
CN108367109B (zh) 2022-01-28
KR20180084125A (ko) 2018-07-24
EP3377139B1 (en) 2021-12-29

Similar Documents

Publication Publication Date Title
KR102837618B1 (ko) 혈액에 산소를 공급하기 위한 투석 시스템 및 투석액에 산소를 공급하기 위한 방법
US11833282B2 (en) Method for extracorporeal carbon dioxide removal
KR102695423B1 (ko) 이산화탄소 제거 시스템
RU2783826C2 (ru) Способы и системы для удаления двуокиси углерода

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)